Sharda Cropchem soars to a record high, up 20% on robust Q3 earnings

EBITDA margin expanded by 220 bps YoY to 22.8 per cent in Q3FY22 driven by economies of scale, effective cost management marginally settled off by higher freight cost.

Topics
Buzzing stocks | Sharda Cropchem | Market trends

SI Reporter  |  Mumbai 

fertilisers
Finished DAP imported prices are expected to remain high because of this.

Shares of rallied 20 per cent, and in the process hit a new all-time high of Rs 454.70, in Monday’s intra-day trade in an otherwise weak market on the back of robust Q3 numbers. The company's Q3 net profit more-than-doubled to Rs 102 crore in December quarter (Q3FY22). The agrochemicals company had posted PAT of Rs 48.3 crore in a year ago quarter.

The company’s revenue grew by 78.2 per cent YoY to Rs 879.8 crore in Q3FY22 led by strong volume growth across geographies & better product mix & price realisation. Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin expanded by 220 bps YoY to 22.8 per cent in Q3 FY22 driven by economies of scale, effective cost management marginally settled off by higher freight cost.

The company’s board declared an interim dividend of Rs 3 per equity share for the financial year 2021-22. The company fixed February 2, 2022 as record date for the purpose of interim dividend. The interim dividend shall be paid or dispatched on or before March 01, 2022, the company said.

Anand Rathi Share and Stock Brokers has a ‘Buy’ rating on with a target price of Rs 480 per share. “Powered by its focus on registering formulations and active ingredient across regions, Sharda’s strong growth would continue. A strong pipeline and distribution network would add to growth. Internally funded capex and FCF generation would strengthen its balance sheet, resulting in higher return ratios,” the brokerage firm said in its initiate coverage report dated December 30, 2021.

Its identification of off-patent high-demand molecules, high registration cost and a long gestation period in registering formulations and active ingredients are high entry barriers, the brokerage firm said.

At 10:30 am; the stock was up 15 per cent at Rs 436 on the BSE, as against a 1.1 per cent decline in the S&P BSE Sensex. The trading volume at the counter jumped three-fold with a combined 3.12 million equity shares changing hands on the NSE and BSE.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Buzzing stocks
First Published: Mon, January 24 2022. 10:59 IST
RECOMMENDED FOR YOU